• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤中枢神经系统转移:当前的治疗方法、挑战与机遇

Melanoma central nervous system metastases: current approaches, challenges, and opportunities.

作者信息

Cohen Justine V, Tawbi Hussain, Margolin Kim A, Amravadi Ravi, Bosenberg Marcus, Brastianos Priscilla K, Chiang Veronica L, de Groot John, Glitza Isabella C, Herlyn Meenhard, Holmen Sheri L, Jilaveanu Lucia B, Lassman Andrew, Moschos Stergios, Postow Michael A, Thomas Reena, Tsiouris John A, Wen Patrick, White Richard M, Turnham Timothy, Davies Michael A, Kluger Harriet M

机构信息

Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.

Department of Melanoma, Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Pigment Cell Melanoma Res. 2016 Nov;29(6):627-642. doi: 10.1111/pcmr.12538. Epub 2016 Oct 22.

DOI:10.1111/pcmr.12538
PMID:27615400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5398760/
Abstract

Melanoma central nervous system metastases are increasing, and the challenges presented by this patient population remain complex. In December 2015, the Melanoma Research Foundation and the Wistar Institute hosted the First Summit on Melanoma Central Nervous System (CNS) Metastases in Philadelphia, Pennsylvania. Here, we provide a review of the current status of the field of melanoma brain metastasis research; identify key challenges and opportunities for improving the outcomes in patients with melanoma brain metastases; and set a framework to optimize future research in this critical area.

摘要

黑色素瘤中枢神经系统转移的情况日益增多,这一患者群体所带来的挑战依然复杂。2015年12月,黑色素瘤研究基金会和维斯达研究所于宾夕法尼亚州费城主办了首届黑色素瘤中枢神经系统转移峰会。在此,我们对黑色素瘤脑转移研究领域的现状进行综述;确定改善黑色素瘤脑转移患者治疗结果的关键挑战和机遇;并建立一个框架以优化这一关键领域的未来研究。

相似文献

1
Melanoma central nervous system metastases: current approaches, challenges, and opportunities.黑色素瘤中枢神经系统转移:当前的治疗方法、挑战与机遇
Pigment Cell Melanoma Res. 2016 Nov;29(6):627-642. doi: 10.1111/pcmr.12538. Epub 2016 Oct 22.
2
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.黑色素瘤中枢神经系统转移:方法、挑战和机遇的更新。
Pigment Cell Melanoma Res. 2019 May;32(3):458-469. doi: 10.1111/pcmr.12771. Epub 2019 Feb 19.
3
Melanoma Brain Metastases: Current Areas of Investigation and Future Directions.黑色素瘤脑转移:当前研究领域与未来方向
Cancer J. 2017 Jan/Feb;23(1):68-74. doi: 10.1097/PPO.0000000000000237.
4
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.黑色素瘤中枢神经系统转移:方法更新、挑战与机遇
Pigment Cell Melanoma Res. 2022 Nov;35(6):554-572. doi: 10.1111/pcmr.13059. Epub 2022 Sep 1.
5
Novel treatments for melanoma brain metastases.黑素瘤脑转移的新治疗方法。
Cancer Control. 2013 Oct;20(4):298-306. doi: 10.1177/107327481302000407.
6
Brain metastases from malignant melanoma.恶性黑色素瘤脑转移
Forum (Genova). 2003;13(2):170-82; quiz 190.
7
Treatment of melanoma brain metastases: a new paradigm.治疗黑色素瘤脑转移:一种新的模式。
Cancer J. 2012 Mar-Apr;18(2):208-12. doi: 10.1097/PPO.0b013e31824b2890.
8
Rodent models of brain metastasis in melanoma.黑色素瘤脑转移的啮齿动物模型
Melanoma Res. 2005 Oct;15(5):325-56. doi: 10.1097/00008390-200510000-00002.
9
Advances in therapy for melanoma brain metastases.黑色素瘤脑转移的治疗进展。
Clin Dermatol. 2013 May-Jun;31(3):264-81. doi: 10.1016/j.clindermatol.2012.08.008.
10
Melanoma in the brain: biology and therapeutic options.脑黑素瘤:生物学与治疗选择。
Melanoma Res. 2012 Jun;22(3):177-83. doi: 10.1097/CMR.0b013e328352dbef.

引用本文的文献

1
Single-cell transcriptome analysis suggests cells of the tumor microenvironment as a major discriminator between brain and extracranial melanoma metastases.单细胞转录组分析表明,肿瘤微环境中的细胞是脑转移黑色素瘤和颅外黑色素瘤转移之间的主要鉴别因素。
Biol Direct. 2025 Sep 16;20(1):97. doi: 10.1186/s13062-025-00691-2.
2
A Pigmented Facial Nodule.一个色素沉着的面部结节。
Indian J Dermatol. 2025 Jul-Aug;70(4):222. doi: 10.4103/ijd.ijd_152_24. Epub 2025 Jun 30.
3
Development and validation of machine learning model to predict early death of melanoma brain metastasis patients.预测黑色素瘤脑转移患者早期死亡的机器学习模型的开发与验证
Front Oncol. 2025 Jul 8;15:1517961. doi: 10.3389/fonc.2025.1517961. eCollection 2025.
4
Pigmented Peril: A fatal case of Primary intracranial melanoma in a paediatric patient.色素沉着的危险:一名儿科患者原发性颅内黑色素瘤致死病例
Radiol Case Rep. 2025 May 1;20(7):3484-3496. doi: 10.1016/j.radcr.2025.03.070. eCollection 2025 Jul.
5
The Role of Radiotherapy in the Management of Melanoma Brain Metastases: An Overview.放射治疗在黑色素瘤脑转移管理中的作用:综述
Curr Treat Options Oncol. 2025 Jan;26(1):36-44. doi: 10.1007/s11864-024-01289-y. Epub 2025 Jan 3.
6
From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway.从试验到实践:挪威黑色素瘤患者的免疫检查点抑制剂治疗
Acta Oncol. 2024 Dec 17;63:965-973. doi: 10.2340/1651-226X.2024.41266.
7
Regorafenib Combined with BRAF/MEK Inhibitors for the Treatment of Refractory Melanoma Brain Metastases.瑞戈非尼联合BRAF/MEK抑制剂治疗难治性黑色素瘤脑转移
Cancers (Basel). 2024 Dec 5;16(23):4083. doi: 10.3390/cancers16234083.
8
Emerging Therapies for Brain Metastases in NSCLC, Breast Cancer, and Melanoma: A Critical Review.非小细胞肺癌、乳腺癌和黑色素瘤脑转移的新兴疗法:批判性综述
Curr Neurol Neurosci Rep. 2024 Dec 3;25(1):6. doi: 10.1007/s11910-024-01388-1.
9
Natural killer cells are required for the recruitment of CD8+ T cells and the efficacy of immune checkpoint blockade in melanoma brain metastases.自然杀伤细胞对于招募 CD8+T 细胞和免疫检查点阻断在黑色素瘤脑转移中的疗效是必需的。
J Immunother Cancer. 2024 Nov 17;12(11):e009522. doi: 10.1136/jitc-2024-009522.
10
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review.针对常见癌症原发灶脑转移的免疫治疗和靶向治疗策略:最新综述
Curr Oncol Rep. 2024 Dec;26(12):1612-1638. doi: 10.1007/s11912-024-01593-8. Epub 2024 Nov 8.

本文引用的文献

1
PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo.PI3K 通路抑制在黑色素瘤脑转移的体外和体内均显示出强大的抗肿瘤活性。
Clin Cancer Res. 2016 Dec 1;22(23):5818-5828. doi: 10.1158/1078-0432.CCR-16-0064. Epub 2016 Jun 15.
2
Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.免疫检查点疗法的时机和类型会影响黑色素瘤脑转移瘤对立体定向放射外科治疗的早期影像学反应。
Cancer. 2016 Oct;122(19):3051-8. doi: 10.1002/cncr.30138. Epub 2016 Jun 10.
3
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.帕博利珠单抗用于治疗黑色素瘤或非小细胞肺癌且伴有未经治疗的脑转移患者:一项非随机、开放标签的2期试验的早期分析
Lancet Oncol. 2016 Jul;17(7):976-983. doi: 10.1016/S1470-2045(16)30053-5. Epub 2016 Jun 3.
4
Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel.内皮素受体双重拮抗剂马昔腾坦联合紫杉醇治疗小鼠实验性人类乳腺癌和肺癌脑转移
Neuro Oncol. 2016 Apr;18(4):486-96. doi: 10.1093/neuonc/now037.
5
Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment.帕博利珠单抗治疗后黑色素瘤脑转移假进展
Cancer Immunol Res. 2016 Mar;4(3):179-82. doi: 10.1158/2326-6066.CIR-15-0160. Epub 2015 Dec 23.
6
Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies.在BRAF抑制剂耐药的患者来源异种移植模型中进行的个性化临床前试验确定了二线联合治疗方案。
Clin Cancer Res. 2016 Apr 1;22(7):1592-602. doi: 10.1158/1078-0432.CCR-15-1762. Epub 2015 Dec 16.
7
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.PTEN缺失促进对T细胞介导的免疫疗法的抗性。
Cancer Discov. 2016 Feb;6(2):202-16. doi: 10.1158/2159-8290.CD-15-0283. Epub 2015 Dec 8.
8
AKT1 Activation Promotes Development of Melanoma Metastases.AKT1激活促进黑色素瘤转移的发展。
Cell Rep. 2015 Nov 3;13(5):898-905. doi: 10.1016/j.celrep.2015.09.057. Epub 2015 Oct 22.
9
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.神经肿瘤学中的免疫治疗反应评估:RANO工作组报告
Lancet Oncol. 2015 Nov;16(15):e534-e542. doi: 10.1016/S1470-2045(15)00088-1.
10
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases.肿瘤浸润淋巴细胞(TILs)和PD-1/PD-L1免疫检查点在人脑转移瘤中的分布及其预后相关性
Oncotarget. 2015 Dec 1;6(38):40836-49. doi: 10.18632/oncotarget.5696.